• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类自然杀伤细胞所表达抗原的特性分析

Characterization of an antigen expressed by human natural killer cells.

作者信息

Griffin J D, Hercend T, Beveridge R, Schlossman S F

出版信息

J Immunol. 1983 Jun;130(6):2947-51.

PMID:6574190
Abstract

A monoclonal antibody, anti-N901, was produced by fusing NS-1 myeloma cells with spleen cells of a mouse immunized with human CML cells. This antibody was reactive with a subpopulation of peripheral blood LGL, including the natural killer cells. Monocytes, granulocytes, B cells, T cells (T3+ cells), erythrocytes, and platelets were nonreactive. The N901-positive cells in the peripheral blood were heterogeneous with respect to expression of other cell surface antigens. The majority of N901+ cells co-expressed T11, Mo1, and HNK-1, whereas a smaller percentage expressed T8. Ia, T3, T4, Mo2, or B1 antigens were very uncommon on N901+ cells. The heterogeneity of the N901+ LGL was further investigated by examining the expression of N901 antigen on a series of cloned normal human NK cell lines. N901 antigen was expressed by each of the NK cell lines tested, and by a minority of cloned T cell lines without NK activity. Anti-N901 does not block NK activity and can be used to rapidly purify functional NK cells for further study.

摘要

通过将NS-1骨髓瘤细胞与用人慢性粒细胞白血病(CML)细胞免疫的小鼠脾细胞融合,制备了一种单克隆抗体——抗-N901。该抗体与外周血大颗粒淋巴细胞(LGL)的一个亚群发生反应,包括自然杀伤细胞。单核细胞、粒细胞、B细胞、T细胞(T3+细胞)、红细胞和血小板无反应。外周血中N901阳性细胞在其他细胞表面抗原的表达方面具有异质性。大多数N901+细胞共表达T11、Mo1和HNK-1,而较小比例的细胞表达T8。Ia、T3、T4、Mo2或B1抗原在N901+细胞上非常罕见。通过检测一系列克隆的正常人自然杀伤细胞系上N901抗原的表达,进一步研究了N901+ LGL的异质性。所测试的每个自然杀伤细胞系以及少数无自然杀伤活性的克隆T细胞系均表达N901抗原。抗-N901不阻断自然杀伤活性,可用于快速纯化功能性自然杀伤细胞以进行进一步研究。

相似文献

1
Characterization of an antigen expressed by human natural killer cells.人类自然杀伤细胞所表达抗原的特性分析
J Immunol. 1983 Jun;130(6):2947-51.
2
The role of interleukin 2 and T11 E rosette antigen in activation and proliferation of human NK clones.白细胞介素2和T11 E玫瑰花结抗原在人自然杀伤细胞克隆激活和增殖中的作用。
J Immunol. 1985 Jul;135(1):672-8.
3
Antigens on human monocytes identified by monoclonal antibodies.通过单克隆抗体鉴定的人类单核细胞上的抗原。
J Immunol. 1981 Apr;126(4):1435-42.
4
Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.快速扩增的活化人杀伤细胞克隆具有强大的抗肿瘤细胞活性,并且具有Tγ、T非γ或裸细胞的表面表型。
J Immunol. 1984 Jun;132(6):3185-91.
5
Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.HNK-1+(Leu-7)人淋巴细胞的特征。I. 具有不同细胞毒性能力的两种不同表型的人自然杀伤细胞。
J Immunol. 1982 Oct;129(4):1752-7.
6
C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.人外周血淋巴细胞表面的C反应蛋白抗原性。与抗新C反应蛋白反应的淋巴细胞的特征。
J Immunol. 1988 Jun 15;140(12):4271-8.
7
Generation of a cloned NK cell line derived from the "null cell" fraction of human peripheral blood.源自人外周血“空细胞”组分的克隆性自然杀伤细胞系的生成。
J Immunol. 1982 Sep;129(3):1299-305.
8
Subpopulations of human natural killer cells defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens.通过Leu-7(HNK-1)和Leu-11(NK-15)抗原表达所定义的人类自然杀伤细胞亚群。
J Immunol. 1983 Oct;131(4):1789-96.
9
Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.针对人自然杀伤细胞克隆的单克隆抗体的产生。对在大颗粒淋巴细胞亚群上表达的两种自然杀伤相关抗原NKH1A和NKH2的特性研究。
J Clin Invest. 1985 Mar;75(3):932-43. doi: 10.1172/JCI111794.
10
Functional characterization of LFA-1 antigens in the interaction of human NK clones and target cells.人自然杀伤细胞克隆与靶细胞相互作用中淋巴细胞功能相关抗原-1(LFA-1)抗原的功能特性
J Immunol. 1985 Aug;135(2):1020-5.

引用本文的文献

1
Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56-positive acute leukemias.具有RAM免疫表型的急性髓系白血病的临床、免疫表型和基因组学发现:与其他CD56阳性急性白血病的比较
EJHaem. 2024 Dec 16;6(1):e1052. doi: 10.1002/jha2.1052. eCollection 2025 Feb.
2
CD56-negative NK cells: Frequency in peripheral blood, expansion during HIV-1 infection, functional capacity, and KIR expression.CD56 阴性 NK 细胞:外周血中的频率、HIV-1 感染期间的扩增、功能能力和 KIR 表达。
Front Immunol. 2022 Sep 23;13:992723. doi: 10.3389/fimmu.2022.992723. eCollection 2022.
3
CD56 expression in breast cancer induces sensitivity to natural killer-mediated cytotoxicity by enhancing the formation of cytotoxic immunological synapse.
CD56 在乳腺癌中的表达通过增强细胞毒性免疫突触的形成诱导自然杀伤细胞介导的细胞毒性敏感性。
Sci Rep. 2019 Jun 19;9(1):8756. doi: 10.1038/s41598-019-45377-8.
4
Standardized assay for assessment of minimal residual disease in blood, bone marrow and apheresis from patients with plasma cell myeloma.用于评估多发性骨髓瘤患者血液、骨髓和单采细胞中微小残留病的标准化检测方法。
Sci Rep. 2019 Feb 27;9(1):2922. doi: 10.1038/s41598-019-39631-2.
5
Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors.IMGN901(一种靶向CD56的抗体药物偶联物)用于CD56阳性实体瘤患者的I期研究。
Invest New Drugs. 2016 Jun;34(3):290-9. doi: 10.1007/s10637-016-0336-9. Epub 2016 Mar 9.
6
Lorvotuzumab mertansine, a CD56-targeting antibody-drug conjugate with potent antitumor activity against small cell lung cancer in human xenograft models.洛伐他汀单抗美登素,一种靶向CD56的抗体药物偶联物,在人异种移植模型中对小细胞肺癌具有强大的抗肿瘤活性。
MAbs. 2014 Mar-Apr;6(2):556-66. doi: 10.4161/mabs.27756. Epub 2014 Jan 8.
7
CD56 positive diffuse large B-cell lymphoma: a case report and literature review.CD56阳性弥漫性大B细胞淋巴瘤:一例报告及文献复习
Int J Clin Exp Pathol. 2013 Nov 15;6(12):3023-5. eCollection 2013.
8
Identification of cytolytic CD161- CD56+ regulatory CD8 T cells in human peripheral blood.鉴定人外周血中的细胞毒性 CD161-CD56+ 调节性 CD8 T 细胞。
PLoS One. 2013;8(3):e59545. doi: 10.1371/journal.pone.0059545. Epub 2013 Mar 19.
9
Drug-conjugated antibodies for the treatment of cancer.用于癌症治疗的药物偶联抗体。
Br J Clin Pharmacol. 2013 Aug;76(2):248-62. doi: 10.1111/bcp.12044.
10
Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, Germany.第四届世界抗体药物偶联物峰会:2012 年 2 月 29 日-3 月 1 日,德国法兰克福。
MAbs. 2012 Nov-Dec;4(6):637-47. doi: 10.4161/mabs.21697. Epub 2012 Aug 22.